| Mrs Melissa Ann Knox, FNP-C | |
|
247 Bluffs Ave Ste 102, Elko, NV 89801-2488 | |
| (775) 738-1212 | |
| Not Available |
| Full Name | Mrs Melissa Ann Knox |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 247 Bluffs Ave Ste 102, Elko, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780354092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 826538 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeastern Nevada Regional Hospital | Elko, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medallus And Vacharothone Ltd | 3072871276 | 10 |
| Morning Star Integrated Health Center Llc | 5597189449 | 2 |
News Archive
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close.
Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.
Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.
If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives.
› Verified 1 days ago
| Entity Name | Medallus & Vacharothone Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902329469 PECOS PAC ID: 3072871276 Enrollment ID: O20171228001478 |
News Archive
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close.
Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.
Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.
If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives.
› Verified 1 days ago
| Entity Name | Morning Star Integrated Health Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952924011 PECOS PAC ID: 5597189449 Enrollment ID: O20200724000084 |
News Archive
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close.
Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.
Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.
If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melissa Ann Knox, FNP-C 808 Abeyta Dr, Spring Creek, NV 89815-5442 Ph: () - | Mrs Melissa Ann Knox, FNP-C 247 Bluffs Ave Ste 102, Elko, NV 89801-2488 Ph: (775) 738-1212 |
News Archive
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close.
Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.
Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.
If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives.
› Verified 1 days ago
Suzanne Windous, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1995 Errecart Blvd Ste 200, Elko, NV 89801 Phone: 775-340-2051 | |
Elizabeth Jean Burlew, A.P.R.N. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1775 Browning Way, Ste 104, Elko, NV 89801 Phone: 775-738-5100 Fax: 775-738-5115 | |
Dr. Irene R Wolf, DNP, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1810 Pinion Rd, Elko, NV 89801 Phone: 775-753-7387 Fax: 775-738-4918 | |
Janine Anderson, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1995 Errecart Blvd Ste 204, Elko, NV 89801 Phone: 775-748-0704 Fax: 775-738-7641 | |
Jane Owen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3740 E Idaho St, Elko, NV 89801 Phone: 775-738-8004 | |
Dr. Allyson C Waldron, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1993 Errecart Blvd, Elko, NV 89801 Phone: 775-753-1049 Fax: 775-777-8494 | |
Iona Michelle Weeks, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1993 Errecart Blvd., Elko, NV 89801 Phone: 775-753-1049 Fax: 775-777-8494 |